Effect of High Altitude on the Survival of COVID-19 Patients in Intensive Care Unit: A Cohort Study
- PMID: 35532089
- PMCID: PMC9095997
- DOI: 10.1177/08850666221099827
Effect of High Altitude on the Survival of COVID-19 Patients in Intensive Care Unit: A Cohort Study
Abstract
Purpose: The effect of high altitude ( ≥ 1500 m) and its potential association with mortality by COVID-19 remains controversial. We assessed the effect of high altitude on the survival/discharge of COVID-19 patients requiring intensive care unit (ICU) admission for mechanical ventilation compared to individuals treated at sea level. Methods: A retrospective cohort multi-center study of consecutive adults patients with a positive RT-PCR test for COVID-19 who were mechanically ventilated between March and November 2020. Data were collected from two sea-level hospitals and four high-altitude hospitals in Ecuador. The primary outcome was ICU and hospital survival/discharge. Survival analysis was conducted using semi-parametric Cox proportional hazards models. Results: Of the study population (n = 670), 35.2% were female with a mean age of 58.3 ± 12.6 years. On admission, high-altitude patients were more likely to be younger (57.2 vs. 60.5 years old), presented with less comorbidities such as hypertension (25.9% vs. 54.9% with p-value <.001) and diabetes mellitus (20.5% vs. 37.2% with p-value <.001), less probability of having a capillary refill time > 3 sec (13.7% vs. 30.1%, p-value <.001), and less severity-of-illness condition (APACHE II score, 17.5 ± 8.1 vs. 20 ± 8.2, p < .01). After adjusting for key confounders high altitude is associated with significant higher probabilities of ICU survival/discharge (HR: 1.74 [95% CI: 1.46-2.08]) and hospital survival/discharge (HR: 1.35 [95% CI: 1.18-1.55]) than patients treated at sea level. Conclusions: Patients treated at high altitude at any time point during the study period were 74% more likely to experience ICU survival/discharge and 35% more likely to experience hospital survival/discharge than to the sea-level group. Possible reasons for these findings are genetic and physiological adaptations due to exposure to chronic hypoxia.
Keywords: COVID-19; ICU; SARS-CoV-2; high altitude; sea level; survival.
Conflict of interest statement
Figures

Similar articles
-
High-altitude is associated with better short-term survival in critically ill COVID-19 patients admitted to the ICU.PLoS One. 2022 Mar 31;17(3):e0262423. doi: 10.1371/journal.pone.0262423. eCollection 2022. PLoS One. 2022. PMID: 35358185 Free PMC article.
-
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394. JAMA. 2020. PMID: 32250385 Free PMC article.
-
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539. JAMA Intern Med. 2020. PMID: 32667669 Free PMC article.
-
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2. Lancet Respir Med. 2021. PMID: 34224674 Free PMC article.
-
Probabilities of ICU admission and hospital discharge according to patient characteristics in the designated COVID-19 hospital of Kuwait.BMC Public Health. 2021 Apr 26;21(1):799. doi: 10.1186/s12889-021-10759-z. BMC Public Health. 2021. PMID: 33902520 Free PMC article.
Cited by
-
Receiver operating characteristic (ROC) to determine cut-off points of clinical and biomolecular markers to discriminate mortality in severe COVID-19 living at high altitude.BMC Pulm Med. 2023 Oct 18;23(1):393. doi: 10.1186/s12890-023-02691-2. BMC Pulm Med. 2023. PMID: 37848858 Free PMC article.
-
Biomarkers as predictors of mortality in critically ill obese patients with COVID-19 at high altitude.BMC Pulm Med. 2023 Apr 6;23(1):112. doi: 10.1186/s12890-023-02399-3. BMC Pulm Med. 2023. PMID: 37024861 Free PMC article.
-
Impact of High-Flow Nasal Cannula Use in Subjects With COVID-19 ARDS at High Altitudes: Clinical Presentation and Prognostic Factors.Respir Care. 2023 Dec 28;69(1):99-105. doi: 10.4187/respcare.10839. Respir Care. 2023. PMID: 37311630 Free PMC article.
-
Risk factors for COVID-19 and their association with mortality in Ecuadorian patients admitted to the ICU: A retrospective cohort multicentric study.Medicine (Baltimore). 2024 Jul 26;103(30):e38776. doi: 10.1097/MD.0000000000038776. Medicine (Baltimore). 2024. PMID: 39058801 Free PMC article.
-
Prediction model for in-hospital mortality in patients at high altitudes with ARDS due to COVID-19.PLoS One. 2023 Oct 26;18(10):e0293476. doi: 10.1371/journal.pone.0293476. eCollection 2023. PLoS One. 2023. PMID: 37883460 Free PMC article.
References
-
- WHO. WHO Coronavirus (COVID-19) dashboard. Published 2021. Accessed February 6, 2022. https://covid19.who.int/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous